NovelFood regulation is now in force. We are repositioning our range to stay transparent with you: sensory oils for external application, ambient potpourri, collector items. Here is what changes, what stays the same, and why we make this choice.
European regulation 2015/2283 on novel foods — known as NovelFood — governs the authorisation of food products containing cannabidiol (CBD) extracted from the plant. As long as no specific authorisation is granted by the European Commission based on an EFSA opinion, CBD products intended for human ingestion remain in a legally unstable zone, particularly in France where the DGCCRF and ANSES have adopted a restrictive reading.
Rather than wait for a decision that could be imposed on us overnight, we are taking the lead. Starting today, our range evolves.
What changes
Three product families are repositioned to stay in step with the current framework:
- CBD oils — now sold as « Sensory oils — aromatic composition, external application ». The recommended use is cutaneous application by massage. References to sublingual use or ingestion are removed from product pages.
- Herbal teas and infusions — repositioned as « Ambient potpourri ». These are aromatic blends to diffuse in the room, not to brew in hot water for consumption. The commercial name is adjusted accordingly.
- Gummies, cookies, chocolates, CBD drinks and other edibles — their pages remain online for transparency, but sales are now disabled. A clear notice explains that they are not available for ordering until the regulatory framework evolves.
What does not change
- Flowers, resins and pollens — Their legal status is that of hemp floral products compliant with the French decree of 30 December 2021 (THC strictly below 0.3%). They are not affected by NovelFood.
- Cosmetics — Balms, creams, massage gels: they already fell under European cosmetic regulation 1223/2009, not under NovelFood. No change.
- E-liquids and vape — Governed by directive TPD 2014/40/EU, outside NovelFood.
- Quality, traceability and our anti-low-cost commitments — Unchanged. We still source from the same batches, the same French and European producers, the same independent testing labs.
Why we make this choice
Three reasons.
First, transparency. We prefer to announce this repositioning clearly rather than continue selling products in an uncertain regulatory zone. You buy with full knowledge.
Second, durability. A shop that gets its products pulled by the DGCCRF overnight serves no one. By anticipating, we stay open tomorrow morning.
Third, reversibility. If tomorrow the NovelFood framework evolves — European authorisation of ingestible CBD, favourable case law, retreat of the ANSES doctrine — we have kept all original wording intact in our systems. Reverting to a "food supplement" positioning would be technically immediate.
In practice, in-store and online
The Boulogne-sur-Gesse and L'Isle-en-Dodon shops stay open with the same hours, the same teams, the same products on the shelves — only the labels and usage advice evolve.
The horus-sas.com site reflects this repositioning immediately in product pages, navigation and documentation.
If you have a question about a specific product or about what this change means for you, drop by in-store or write to us: advice remains free and jargon-free.
Our craft stays the same: sourcing premium hemp, distributing it honestly, supporting our customers without overpromise. The framework evolves, so does our standard.
This article is informative. For specific legal advice, consult a lawyer. Horus products are not medicines.